Skip to Content

NOVAST 33 (Nifedipine Extended-Release 30 mg)

Pill with imprint NOVAST 33 is Yellow, Round and has been identified as Nifedipine Extended-Release 30 mg. It is supplied by Ingenus Pharmaceuticals, LLC.

Nifedipine is used in the treatment of high blood pressure; hypertensive emergency; angina pectoris prophylaxis; heart failure; raynaud's syndrome and belongs to the drug class calcium channel blocking agents. Risk cannot be ruled out during pregnancy. Nifedipine 30 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for NOVAST 33

Nifedipine extended-release 30 mg NOVAST 33

Nifedipine Extended-Release

Imprint
NOVAST 33
Strength
30 mg
Color
Yellow
Size
9.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Calcium channel blocking agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Ingenus Pharmaceuticals, LLC
National Drug Code (NDC)
50742-0620
Inactive Ingredients
lactose monohydrate, microcrystalline cellulose, hypromelloses, magnesium stearate, polyvinyl alcohol, magnesium silicate, titanium dioxide, polyethylene glycol 3350, soya lecithin, ferric oxide yellow, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.